Last reviewed · How we verify

NCT05049941

Blood Gases Versus Lactate Clearance as an Indicator of Initial Resuscitation in Septic Patients: Comparative Study

Status unknown Last updated 20 September 2021
What this trial tests

trial testing lactat and blood gases in Sepsis Syndrome in 120 participants. Status unknown.

Timeline
15 August 2021
Primary endpoint
15 November 2021
15 December 2021

Quick facts

Lead sponsorMinia University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date15 August 2021
Primary completion15 November 2021
Estimated completion15 December 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 18 to 65, any sex, with Sepsis Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

\- This perspective blind randomized single center study was designed to assess central venous and arterial gases level including P(v-a)CO2/C(a-v)O2 ratio and P(v-a)CO2 difference against lactate clearance as an indicator of initial resuscitation in septic patients in intensive care unit and to evaluate the success of early resuscitation protocol .this continuation of our previous work we compared the ratio of P(v-a)CO2/C(a-v)O2 ratio against lactate clearance(8). Mortality in the ICU in the study groups will be recorded

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sepsis Syndrome

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05049941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing